A Single Ascending Dose of HRS-2162 in Healthy Subjects

NCT07195604 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Reversal of Neuromuscular Blockade

Interventions

DRUG: HRS-2162
DRUG: Placebo

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.